• Please log in or register to access this feature.

Original Article

You have full text access to this OnlineOpen article

Comparative screening with a sensitive guaiac and specific immunochemical occult blood test in an endoscopic study

  1. Paul Rozen M.B., B.S.*,
  2. Judith Knaani,
  3. Ziona Samuel

Article first published online: 13 NOV 2000

DOI: 10.1002/1097-0142(20000701)89:1<46::AID-CNCR7>3.0.CO;2-9

Issue

Cancer

Cancer

Volume 89, Issue 1, pages 46–52, 1 July 2000

Additional Information

How to Cite

Rozen, P., Knaani, J. and Samuel, Z. (2000), Comparative screening with a sensitive guaiac and specific immunochemical occult blood test in an endoscopic study. Cancer, 89: 46–52. doi: 10.1002/1097-0142(20000701)89:1<46::AID-CNCR7>3.0.CO;2-9

Author Information

  1. Gastroenterology Department, Tel Aviv Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

*Department of Gastroenterology, Tel Aviv Medical Center, 6 Weizmann Street, Tel Aviv 64239, Israel

Publication History

  1. Issue published online: 13 NOV 2000
  2. Article first published online: 13 NOV 2000
  3. Manuscript Revised: 22 FEB 2000
  4. Manuscript Accepted: 22 FEB 2000
  5. Manuscript Received: 27 SEP 1999

Funded by

  • Research Authorities of the Tel Aviv Medical Center through a contract with SmithKline Diagnostics (California)
  • Israel Cancer Association

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (80K)

REFERENCES

  • 1
    Young GP, St. John DJB. Selecting an occult blood test for use as a screening tool for large bowel cancer. In: RozenP, ReichCB, WinawerSJ, editors. Large bowel cancer: policy, prevention, research and treatment. Basel: Karger, 1991: 135–56.
  • 2
    Young GP, Macrae FA, St. John DJB. Clinical methods for early detection: basis, use and evaluation. In: YoungGP, RozenP, LevinB, editors. Prevention and early detection of colorectal cancer. London: Saunders, 1996; 241–70.
  • 3
    Petty MT, Deacon MC, Alexeyeff MA, St. John DJB, Young GP. Readability and sensitivity of a new faecal occult blood test in a hospital ward environment. Med J Aust 1992; 156: 420–3.
  • 4
    St. John DJB, Young GP, Alexeyeff MA, Deacon MC, Cuthbertson AM, Macrae F, et al. Evaluation of new occult blood tests for detection of colorectal neoplasia. Gastroenterology 1993; 104: 1661–8.
  • 5
    Rozen P, Knaani, J, Papo N. Evaluation and comparison of an immunochemical and a guaiac faecal occult blood screening test for colorectal neoplasia. Eur J Cancer Prev 1995; 4: 475–81.
  • 6
    Petrelli N, Michalek AM, Freedman A, Baroni M, Mink I, Rodriguez-Bigas M. Immunochemical versus guaiac occult blood stool tests: results of a community-based screening program. Surg Oncol 1994; 3: 27–36.
  • 7
    Levin B, Hess K, Johnson C. A comparison of 3 fecal occult blood tests. Arch Intern Med 1997; 157: 970–6.
  • 8
    Allison JE, Tekawa IS, Ransom LJ, Adrian AL. A comparison of fecal occult-blood tests for colorectal-cancer screening. N Engl J Med 1996; 334: 155–9.
  • 9
    Rozen P, Knaani J, Samuel Z. Performance characteristics and comparison of two immunochemical and two guaiac fecal occult blood screening tests for colorectal neoplasia. Dig Dis Sci 1997; 42: 2064–71.
  • 10
    Ransohoff DF, Lang CA. Screening for colorectal cancer with the fecal occult blood test: a background paper. Ann Int Med 1997; 126: 811–22.
  • 11
    Allison JE. Review article: fecal occult blood testing for colorectal cancer. Aliment Pharmacol Ther 1998; 12: 1–10.
    Direct Link:
  • 12
    Nakama H, Kamijo N, Miyata K, Fattah ASMA, Zhang B, Uehara Y. Sensitivity and specificity of several immunochemical tests for colorectal cancer. Hepato-Gastroenterol 1998; 45: 1579–82.
  • 13
    Sinatra MA, St. John DJB, Young GP. Interference by plant peroxidases with guaiac based fecal occult blood tests is avoidable. Clin Chem 1999; 45: 123–6.
  • 14
    Rozen P, Knaani J, Samuel Z. Eliminating the need for dietary restrictions when using a sensitive guaiac fecal occult blood test. Dig Dis Sci 1999; 44: 756–60.
  • 15
    Rozen P. Screening for colorectal cancer in the Tel-Aviv area: cumulative data 1979–1989 and initial conclusions. Isr J Med Sci 1992; 28(Suppl): 8–20.
  • 16
    Hemoccult®SENSA®. Product instructions. Palo Alto, CA: Beckman Coulter, Inc., 1999.
  • 17
    Fattah ASMA, Nakama H, Kamijo N, Fujimori K, Zhang B. Colorectal adenomatous polyps detected by immunochemical occult blood screening. Hepato-Gastroenterol 1998; 45: 712–6.
  • 18
    Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, et al. for the Minnesota Colon Cancer Control Study. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 1993;328: 1365–71.
  • 19
    Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996; 348: 1467–71.
  • 20
    Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, et al. Randomized controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996; 348: 1472–7.
  • 21
    Ransohoff DF, Lang CA. Improving the fecal occult blood test [editorial]. N Engl J Med 1996; 334: 139–40.
  • 22
    Saito H, Yoshida Y. Mass screening: Japanese perspective. In: YoungGP, RozenP, LevinB, editors. Prevention and early detection of colorectal cancer. London: Saunders, 1996: 301–11.
  • 23
    Rozen P. Colorectal cancer screening in Israel. Gastrointest Endosc 1998; 47: 97–8.
View Full Article (HTML) Get PDF (80K)